Objective: We sought to evaluate the efficacy and safety of vildagliptin, a new dipeptidyl peptidase-4 inhibitor, added to metformin during 24 weeks of treatment in patients with type 2 diabetes.

2008 - European health authorities have approved Eucreas®, an oral tablet combining Galvus® (vildagliptin) and metformin, as a new treatment for patients with type 2 diabetes. Eucreas is the ...

Review the side-effects of Vildagliptin as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority ...

Study A was supported by Novartis, which supplied the vildagliptin and matching placebo tablets. Study B was funded by Merck Sharp & Dohme, which arranged the supply of metformin and placebo.

Vildagliptin SR and Metformin SR tablets merge the potent mechanisms of vildagliptin and metformin to offer patients a comprehensive approach to managing their glycemic levels. Vildagliptin ...

A recent study has found that a single dose of the DPP-IV inhibitor vildagliptin caused a significant suppression of endogenous glucose production in patients with type 2 diabetes.

French spirits group Remy Cointreau on Wednesday abandoned its 2030 sales growth ambitions, saying tariffs, persistently slow U.S. sales and high levels of uncertainty could derail its plans for ...

Details concerning the Vildagliptin combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments ...

Currently the branded versions of Vildagliptin controlled by Novartis are sold at prices between Rs 20 and Rs 28 per tablet. On E-pharmacy portal 1Mg - Natco Pharma and Vivifi Life Sciences have ...

In contrast, in the group receiving 50 mg vildagliptin daily, more than two-thirds of patients experienced meaningful (37.8%) or marked (29.4%) improvement in glycemic control. In the group ...